“They voted that the benefits of the COVID vaccine for 5- to 11-year-olds outweighed the risks,” Kimberlin said. “I would anticipate over the next few days we would have a full authorization from the FDA … and on I think Tuesday of next week the CDC will have their own external advisory committee that will also look at these data and will make a recommendation as to whether or not the vaccine should be used. So FDA says it may be used, CDC says how it should be used.”